Cargando…
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century with more than 257 million cases and over 5.17 million deaths reported worldwide (as of November 23, 2021. Various agents were initially proclaimed to be effective against SARS-CoV-2, the etiological agent of CO...
Autores principales: | Drożdżal, Sylwester, Rosik, Jakub, Lechowicz, Kacper, Machaj, Filip, Szostak, Bartosz, Przybyciński, Jarosław, Lorzadeh, Shahrokh, Kotfis, Katarzyna, Ghavami, Saeid, Łos, Marek J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654464/ https://www.ncbi.nlm.nih.gov/pubmed/34991982 http://dx.doi.org/10.1016/j.drup.2021.100794 |
Ejemplares similares
-
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
por: Drożdżal, Sylwester, et al.
Publicado: (2020) -
COVID-19: Pain Management in Patients with SARS-CoV-2 Infection—Molecular Mechanisms, Challenges, and Perspectives
por: Drożdżal, Sylwester, et al.
Publicado: (2020) -
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
por: Lechowicz, Kacper, et al.
Publicado: (2020) -
Kidney damage from nonsteroidal anti‐inflammatory drugs—Myth or truth? Review of selected literature
por: Drożdżal, Sylwester, et al.
Publicado: (2021) -
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
por: Sieńko, Jerzy, et al.
Publicado: (2020)